GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:003223315 | Prostate | BPH | positive regulation of actin filament bundle assembly | 26/3107 | 63/18723 | 2.96e-06 | 4.67e-05 | 26 |
GO:00975819 | Prostate | BPH | lamellipodium organization | 32/3107 | 90/18723 | 1.01e-05 | 1.41e-04 | 32 |
GO:00459265 | Prostate | BPH | negative regulation of growth | 68/3107 | 249/18723 | 1.26e-05 | 1.69e-04 | 68 |
GO:003812710 | Prostate | BPH | ERBB signaling pathway | 39/3107 | 121/18723 | 1.69e-05 | 2.11e-04 | 39 |
GO:19021172 | Prostate | BPH | positive regulation of organelle assembly | 25/3107 | 67/18723 | 3.63e-05 | 3.96e-04 | 25 |
GO:00311225 | Prostate | BPH | cytoplasmic microtubule organization | 22/3107 | 56/18723 | 4.21e-05 | 4.48e-04 | 22 |
GO:005165118 | Prostate | BPH | maintenance of location in cell | 58/3107 | 214/18723 | 6.67e-05 | 6.61e-04 | 58 |
GO:000717310 | Prostate | BPH | epidermal growth factor receptor signaling pathway | 34/3107 | 108/18723 | 9.70e-05 | 9.04e-04 | 34 |
GO:00033823 | Prostate | BPH | epithelial cell morphogenesis | 15/3107 | 33/18723 | 9.91e-05 | 9.20e-04 | 15 |
GO:00300489 | Prostate | BPH | actin filament-based movement | 38/3107 | 127/18723 | 1.31e-04 | 1.18e-03 | 38 |
GO:00514968 | Prostate | BPH | positive regulation of stress fiber assembly | 20/3107 | 52/18723 | 1.31e-04 | 1.18e-03 | 20 |
GO:005123516 | Prostate | BPH | maintenance of location | 80/3107 | 327/18723 | 1.55e-04 | 1.36e-03 | 80 |
GO:00604919 | Prostate | BPH | regulation of cell projection assembly | 51/3107 | 188/18723 | 1.73e-04 | 1.48e-03 | 51 |
GO:012003210 | Prostate | BPH | regulation of plasma membrane bounded cell projection assembly | 50/3107 | 186/18723 | 2.53e-04 | 2.00e-03 | 50 |
GO:00454447 | Prostate | BPH | fat cell differentiation | 59/3107 | 229/18723 | 2.60e-04 | 2.04e-03 | 59 |
GO:00303083 | Prostate | BPH | negative regulation of cell growth | 50/3107 | 188/18723 | 3.33e-04 | 2.52e-03 | 50 |
GO:00300327 | Prostate | BPH | lamellipodium assembly | 24/3107 | 72/18723 | 3.85e-04 | 2.83e-03 | 24 |
GO:01200345 | Prostate | BPH | positive regulation of plasma membrane bounded cell projection assembly | 31/3107 | 105/18723 | 6.72e-04 | 4.50e-03 | 31 |
GO:19021154 | Prostate | BPH | regulation of organelle assembly | 48/3107 | 186/18723 | 8.91e-04 | 5.72e-03 | 48 |
GO:00301786 | Prostate | BPH | negative regulation of Wnt signaling pathway | 43/3107 | 170/18723 | 2.42e-03 | 1.31e-02 | 43 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
CCDC8 | SNV | Missense_Mutation | | c.704N>T | p.Gly235Val | p.G235V | Q9H0W5 | protein_coding | deleterious_low_confidence(0) | possibly_damaging(0.571) | TCGA-AN-A0AK-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
CCDC8 | SNV | Missense_Mutation | rs752421136 | c.1234G>A | p.Val412Ile | p.V412I | Q9H0W5 | protein_coding | tolerated_low_confidence(0.48) | benign(0) | TCGA-BH-A1FH-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unknown | Unknown | PD |
CCDC8 | SNV | Missense_Mutation | | c.1463G>T | p.Trp488Leu | p.W488L | Q9H0W5 | protein_coding | deleterious_low_confidence(0) | probably_damaging(0.998) | TCGA-C8-A275-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
CCDC8 | SNV | Missense_Mutation | rs764873641 | c.112N>T | p.Arg38Trp | p.R38W | Q9H0W5 | protein_coding | deleterious_low_confidence(0) | benign(0.095) | TCGA-C5-A1ML-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | PD |
CCDC8 | SNV | Missense_Mutation | | c.583N>T | p.Arg195Trp | p.R195W | Q9H0W5 | protein_coding | deleterious_low_confidence(0) | probably_damaging(0.995) | TCGA-EK-A2PM-01 | Cervix | cervical & endocervical cancer | Female | >=65 | I/II | Unknown | Unknown | SD |
CCDC8 | SNV | Missense_Mutation | | c.290N>G | p.Tyr97Cys | p.Y97C | Q9H0W5 | protein_coding | deleterious_low_confidence(0) | probably_damaging(0.973) | TCGA-A6-2686-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
CCDC8 | SNV | Missense_Mutation | rs754734333 | c.1373N>T | p.Ala458Val | p.A458V | Q9H0W5 | protein_coding | tolerated_low_confidence(0.06) | benign(0.007) | TCGA-A6-6781-01 | Colorectum | colon adenocarcinoma | Male | <65 | III/IV | Chemotherapy | oxaliplatin | SD |
CCDC8 | SNV | Missense_Mutation | | c.292N>A | p.Asp98Asn | p.D98N | Q9H0W5 | protein_coding | deleterious_low_confidence(0) | probably_damaging(0.997) | TCGA-AA-3510-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
CCDC8 | SNV | Missense_Mutation | | c.960N>T | p.Arg320Ser | p.R320S | Q9H0W5 | protein_coding | deleterious_low_confidence(0.01) | benign(0.33) | TCGA-AA-3815-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
CCDC8 | SNV | Missense_Mutation | | c.1577N>C | p.Arg526Thr | p.R526T | Q9H0W5 | protein_coding | deleterious_low_confidence(0) | possibly_damaging(0.719) | TCGA-AA-3819-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |